Updated on 7 November 2013
The new institute has identified several initial projects such as a new anti-glaucoma nanomedicine. Injected only twice yearly to replace the current daily eye drops, the nanomedicine reduces high eye-pressure, which if left untreated can lead to blindness.
Another project in the works is the new drug-eluting balloon, which can deliver drugs in nano form over a long period of time to prevent re-occurrence of cardiovascular plaque that narrow the arteries.
Professor Freddy Boey, a serial inventor and a nanoscience expert, said the new institute will build upon the university's success in nanomaterials to develop innovative diagnostic and therapeutic medicine that will address medical needs which are currently unmet.
"The use of Nanomaterials for medical applications is today, one of the most exciting frontiers, enabling solutions for unmet needs never thought possible previously," Prof Boey said.
"NTU has already produced some "first-in-the-world" solutions using nanomaterials for cardiovascular and ophthalmology diseases. There are still many, many unmet medical needs, for example, in the area of diabetes. This effort will help Singapore and NTU to be at the forefront in developing disruptive solutions for unmet medical needs globally. "